NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

UK ministers are considering increasing NHS payments to pharmaceutical companies by up to 25% to resolve ongoing disputes with the industry and the Trump administration. This move comes after concerns that the standoff has led to reduced investments from drugmakers in the UK. The Labour party is also proposing new measures to address these issues, highlighting the importance of ensuring access to affordable medicines for the public.